reports
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Simon Granath
- ABGSC Services Research
- Simon Jönsson
- ABGSC Healthcare Research
- Sten Gustafsson
- ABGSC Healthcare Research
- Sten Gustafsson
- ABGSC Healthcare Research
- Sten Gustafsson
Thule Group AB: 2 directors
Two Directors at Thule Group AB bought/maiden bought 1,465 shares at between 200.600SEK and 203.200SEK. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Simon Granath
- ABGSC Healthcare Research
- Sten Gustafsson
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Simon Granath
- ABGSC Services Research
- Julia Sundvall
- Simon Jönsson
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Simon Granath
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Simon Granath
- ABGSC Healthcare Research
- Sten Gustafsson
- ABGSC Healthcare Research
- Sten Gustafsson
Bonesupport Holding AB: 1 director
A director at Bonesupport Holding AB bought 13,738 shares at 189.691SEK and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Simon Granath
- ABGSC Healthcare Research
- Sten Gustafsson
CTT Systems AB: 1 director
A director at CTT Systems AB bought 1,400 shares at 132.320SEK and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- ABGSC Healthcare Research
- Sten Gustafsson
- ABGSC Healthcare Research
- Sten Gustafsson
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.